Share Price and Basic Stock Data
Last Updated: January 16, 2026, 11:38 pm
| PEG Ratio | -1.11 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Moongipa Capital Finance Ltd operates as a Non-Banking Financial Company (NBFC) and recorded a market capitalization of ₹15.1 Cr with a share price of ₹16.5. Revenue from operations has exhibited notable fluctuations, with sales standing at ₹1.83 Cr for the financial year ending March 2023. However, there was a significant recovery in revenue, reaching ₹9.25 Cr for March 2024, and trailing twelve months (TTM) revenue amounted to ₹10.31 Cr. Quarterly data reveals a remarkable increase in sales from ₹0.27 Cr in March 2023 to ₹2.62 Cr in September 2023, indicating a strong upward trend. Despite these positive indicators, revenue remains below historical highs, suggesting that operational consistency is a key area for improvement. The company’s ability to sustain this growth trajectory will be critical as it navigates market dynamics in the competitive NBFC sector.
Profitability and Efficiency Metrics
Moongipa Capital Finance Ltd reported a net profit of ₹1.34 Cr, with a return on equity (ROE) of 9.43% and a return on capital employed (ROCE) of 12.1%. The operating profit margin (OPM) was recorded at 21.01%, showcasing the company’s capacity to maintain profitability despite operational challenges. However, the company experienced negative operating profits in several quarters, particularly in March 2023, where the OPM was -277.78%. The interest coverage ratio (ICR) stood at a robust 29.55x, indicating that the company can comfortably meet its interest obligations. Furthermore, the cash conversion cycle (CCC) was relatively lengthy at 481.53 days, which may indicate inefficiencies in working capital management. Overall, while profitability metrics are promising, the company must address its operational inefficiencies to enhance its bottom line.
Balance Sheet Strength and Financial Ratios
The balance sheet of Moongipa Capital Finance Ltd reflects a total asset value of ₹30.54 Cr, with total liabilities amounting to ₹6.60 Cr. The company reported reserves of ₹15.21 Cr and borrowings of ₹7.45 Cr, resulting in a low debt-to-equity ratio of 0.30, which is favorable compared to industry standards. The price-to-book value (P/BV) ratio stood at 0.77x, suggesting that the stock may be undervalued relative to its book value. Financial ratios indicate a current ratio of 4.29x and a quick ratio of 3.29x, both of which demonstrate strong liquidity positions. However, the company must remain vigilant as its working capital days have increased to 875.92, indicating potential challenges in managing receivables and inventory effectively. These balance sheet metrics provide a solid foundation for future growth, contingent on improving operational efficiency.
Shareholding Pattern and Investor Confidence
Moongipa Capital Finance Ltd’s shareholding structure indicates a stable ownership distribution, with promoters holding 37.39% and the public holding 62.61%. The number of shareholders has grown from 4,221 in December 2022 to 5,771 by September 2025, reflecting increasing investor interest and confidence in the company. The absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) suggests a potential opportunity for attracting institutional investment, which could enhance the company’s credibility in the market. The consistent promoter holding indicates a commitment to the business, which is a positive signal for retail investors. Nevertheless, the high public ownership may lead to increased volatility in share price due to market sentiment, necessitating effective communication from the management to assure shareholders of the company’s strategic direction and operational performance.
Outlook, Risks, and Final Insight
The outlook for Moongipa Capital Finance Ltd appears cautiously optimistic, supported by its recent revenue growth and sound financial metrics. However, the company faces risks, including operational inefficiencies reflected in its lengthy cash conversion cycle and past negative operating profits. Additionally, the absence of institutional investors may limit access to larger pools of capital for expansion. To capitalize on growth opportunities, the company must focus on enhancing operational efficiencies and managing working capital effectively. If it successfully addresses these challenges, Moongipa Capital could solidify its position in the NBFC sector. Conversely, failure to improve profitability and manage operational risks could hinder its growth trajectory. Stakeholders should monitor the company’s strategic initiatives closely, as the current market conditions present both opportunities and challenges in the evolving financial landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 13.6 Cr. | 1.36 | 1.91/1.00 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 7.23 Cr. | 0.72 | 7.55/0.62 | 21.3 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 402 Cr. | 61.5 | 125/53.9 | 40.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 15.2 Cr. | 16.5 | 26.2/15.0 | 12.5 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 32.8 Cr. | 73.0 | 152/66.1 | 17.6 | 238 | 1.37 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 28,813.29 Cr | 401.05 | 52.39 | 515.00 | 0.23% | 15.81% | 8.84% | 8.50 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.45 | 0.60 | 0.27 | 1.04 | 2.62 | 2.76 | 3.02 | 3.31 | 2.32 | 2.16 | 1.10 | 3.10 | 3.95 |
| Expenses | 0.16 | 0.52 | 1.02 | 0.58 | 1.98 | 2.07 | 3.17 | 2.05 | 1.72 | 1.79 | 1.44 | 1.74 | 3.12 |
| Operating Profit | 0.29 | 0.08 | -0.75 | 0.46 | 0.64 | 0.69 | -0.15 | 1.26 | 0.60 | 0.37 | -0.34 | 1.36 | 0.83 |
| OPM % | 64.44% | 13.33% | -277.78% | 44.23% | 24.43% | 25.00% | -4.97% | 38.07% | 25.86% | 17.13% | -30.91% | 43.87% | 21.01% |
| Other Income | 0.00 | 0.03 | 0.12 | 0.08 | 0.12 | 0.06 | 0.11 | 0.06 | 0.10 | 0.07 | 0.11 | 0.05 | 0.08 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.17 | 0.16 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
| Profit before tax | 0.27 | 0.09 | -0.65 | 0.53 | 0.74 | 0.73 | -0.06 | 1.31 | 0.69 | 0.43 | -0.31 | 1.22 | 0.73 |
| Tax % | 14.81% | 11.11% | -4.62% | 9.43% | 12.16% | 19.18% | -133.33% | 22.90% | 18.84% | 18.60% | 70.97% | 22.95% | 23.29% |
| Net Profit | 0.22 | 0.08 | -0.62 | 0.48 | 0.65 | 0.59 | 0.02 | 1.01 | 0.56 | 0.35 | -0.53 | 0.95 | 0.57 |
| EPS in Rs | 0.24 | 0.09 | -0.67 | 0.52 | 0.71 | 0.64 | 0.02 | 1.10 | 0.61 | 0.38 | -0.58 | 1.04 | 0.62 |
Last Updated: January 6, 2026, 7:35 pm
Below is a detailed analysis of the quarterly data for Moongipa Capital Finance Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 3.95 Cr.. The value appears strong and on an upward trend. It has increased from 3.10 Cr. (Jun 2025) to 3.95 Cr., marking an increase of 0.85 Cr..
- For Expenses, as of Sep 2025, the value is 3.12 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.74 Cr. (Jun 2025) to 3.12 Cr., marking an increase of 1.38 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.83 Cr.. The value appears to be declining and may need further review. It has decreased from 1.36 Cr. (Jun 2025) to 0.83 Cr., marking a decrease of 0.53 Cr..
- For OPM %, as of Sep 2025, the value is 21.01%. The value appears to be declining and may need further review. It has decreased from 43.87% (Jun 2025) to 21.01%, marking a decrease of 22.86%.
- For Other Income, as of Sep 2025, the value is 0.08 Cr.. The value appears strong and on an upward trend. It has increased from 0.05 Cr. (Jun 2025) to 0.08 Cr., marking an increase of 0.03 Cr..
- For Interest, as of Sep 2025, the value is 0.16 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.17 Cr. (Jun 2025) to 0.16 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Sep 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.02 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.73 Cr.. The value appears to be declining and may need further review. It has decreased from 1.22 Cr. (Jun 2025) to 0.73 Cr., marking a decrease of 0.49 Cr..
- For Tax %, as of Sep 2025, the value is 23.29%. The value appears to be increasing, which may not be favorable. It has increased from 22.95% (Jun 2025) to 23.29%, marking an increase of 0.34%.
- For Net Profit, as of Sep 2025, the value is 0.57 Cr.. The value appears to be declining and may need further review. It has decreased from 0.95 Cr. (Jun 2025) to 0.57 Cr., marking a decrease of 0.38 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.62. The value appears to be declining and may need further review. It has decreased from 1.04 (Jun 2025) to 0.62, marking a decrease of 0.42.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.54 | 0.66 | 0.64 | 1.11 | 1.06 | 0.88 | 0.59 | 1.24 | 3.70 | 1.83 | 9.25 | 8.78 | 10.31 |
| Expenses | 0.53 | 0.57 | 0.78 | 0.65 | 0.56 | 1.55 | 1.16 | 0.42 | 0.61 | 4.14 | 7.61 | 6.85 | 8.09 |
| Operating Profit | 0.01 | 0.09 | -0.14 | 0.46 | 0.50 | -0.67 | -0.57 | 0.82 | 3.09 | -2.31 | 1.64 | 1.93 | 2.22 |
| OPM % | 1.85% | 13.64% | -21.88% | 41.44% | 47.17% | -76.14% | -96.61% | 66.13% | 83.51% | -126.23% | 17.73% | 21.98% | 21.53% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.36 | 0.00 | 0.00 | 0.01 | 0.03 | 0.00 | 0.15 | 0.37 | 0.31 | 0.31 |
| Interest | 0.03 | 0.02 | 0.00 | 0.00 | 0.03 | 0.04 | 0.02 | 0.01 | 0.00 | 0.01 | 0.00 | 0.08 | 0.40 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.07 | 0.08 | 0.06 | 0.05 | 0.06 |
| Profit before tax | -0.04 | 0.05 | -0.16 | 0.80 | 0.45 | -0.72 | -0.60 | 0.82 | 3.02 | -2.25 | 1.95 | 2.11 | 2.07 |
| Tax % | 25.00% | 60.00% | 0.00% | 10.00% | 20.00% | -22.22% | 0.00% | 48.78% | 18.87% | -32.89% | 10.26% | 35.07% | |
| Net Profit | -0.05 | 0.02 | -0.16 | 0.71 | 0.36 | -0.55 | -0.60 | 0.42 | 2.45 | -1.52 | 1.75 | 1.38 | 1.34 |
| EPS in Rs | -0.05 | 0.02 | -0.17 | 0.77 | 0.39 | -0.60 | -0.65 | 0.46 | 2.66 | -1.65 | 1.90 | 1.51 | 1.46 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 140.00% | -900.00% | 543.75% | -49.30% | -252.78% | -9.09% | 170.00% | 483.33% | -162.04% | 215.13% | -21.14% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1040.00% | 1443.75% | -593.05% | -203.48% | 243.69% | 179.09% | 313.33% | -645.37% | 377.17% | -236.27% |
Moongipa Capital Finance Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 72% |
| 3 Years: | 33% |
| TTM: | -26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 53% |
| 5 Years: | 34% |
| 3 Years: | -17% |
| TTM: | -41% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 62% |
| 3 Years: | 9% |
| 1 Year: | -42% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 13% |
| 3 Years: | 6% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: December 4, 2025, 3:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 9.16 | 9.16 |
| Reserves | 0.50 | 0.51 | 0.35 | 1.06 | 1.42 | 0.87 | 0.26 | 0.68 | 3.13 | 1.61 | 3.35 | 13.70 | 15.21 |
| Borrowings | 0.26 | 0.05 | 0.40 | 0.25 | 0.61 | 0.31 | 0.31 | 0.00 | 0.00 | 0.12 | 0.00 | 7.01 | 7.45 |
| Other Liabilities | 0.04 | 0.03 | 0.02 | 0.08 | 0.03 | 0.06 | 0.05 | 0.21 | 0.78 | 0.06 | 0.20 | 0.67 | 0.82 |
| Total Liabilities | 3.85 | 3.64 | 3.82 | 4.44 | 5.11 | 4.29 | 3.67 | 3.94 | 6.96 | 4.84 | 6.60 | 30.54 | 32.64 |
| Fixed Assets | 0.07 | 0.04 | 0.07 | 0.05 | 0.04 | 0.03 | 0.07 | 0.05 | 0.31 | 0.23 | 0.18 | 0.13 | 0.20 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.88 | 0.93 | 1.33 | 1.47 | 1.65 | 0.96 | 1.60 | 2.58 | 5.34 | 2.64 | 1.43 | 6.85 | 6.57 |
| Other Assets | 2.90 | 2.67 | 2.42 | 2.92 | 3.42 | 3.30 | 2.00 | 1.31 | 1.31 | 1.97 | 4.99 | 23.56 | 25.87 |
| Total Assets | 3.85 | 3.64 | 3.82 | 4.44 | 5.11 | 4.29 | 3.67 | 3.94 | 6.96 | 4.84 | 6.60 | 30.54 | 32.64 |
Below is a detailed analysis of the balance sheet data for Moongipa Capital Finance Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 9.16 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.16 Cr..
- For Reserves, as of Sep 2025, the value is 15.21 Cr.. The value appears strong and on an upward trend. It has increased from 13.70 Cr. (Mar 2025) to 15.21 Cr., marking an increase of 1.51 Cr..
- For Borrowings, as of Sep 2025, the value is 7.45 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 7.01 Cr. (Mar 2025) to 7.45 Cr., marking an increase of 0.44 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.82 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.67 Cr. (Mar 2025) to 0.82 Cr., marking an increase of 0.15 Cr..
- For Total Liabilities, as of Sep 2025, the value is 32.64 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.54 Cr. (Mar 2025) to 32.64 Cr., marking an increase of 2.10 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.20 Cr.. The value appears strong and on an upward trend. It has increased from 0.13 Cr. (Mar 2025) to 0.20 Cr., marking an increase of 0.07 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 6.57 Cr.. The value appears to be declining and may need further review. It has decreased from 6.85 Cr. (Mar 2025) to 6.57 Cr., marking a decrease of 0.28 Cr..
- For Other Assets, as of Sep 2025, the value is 25.87 Cr.. The value appears strong and on an upward trend. It has increased from 23.56 Cr. (Mar 2025) to 25.87 Cr., marking an increase of 2.31 Cr..
- For Total Assets, as of Sep 2025, the value is 32.64 Cr.. The value appears strong and on an upward trend. It has increased from 30.54 Cr. (Mar 2025) to 32.64 Cr., marking an increase of 2.10 Cr..
Notably, the Reserves (15.21 Cr.) exceed the Borrowings (7.45 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.25 | 0.04 | -0.54 | 0.21 | -0.11 | -0.98 | -0.88 | 0.82 | 3.09 | -2.43 | 1.64 | -5.08 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1,013.89 | 1,249.85 | 216.72 | 85.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.96 | 7.10 | 50.72 |
| Inventory Days | 463.06 | 199.54 | 430.81 | |||||||||
| Days Payable | 0.00 | 0.00 | 0.00 | |||||||||
| Cash Conversion Cycle | 1,013.89 | 1,249.85 | 216.72 | 85.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 477.02 | 206.64 | 481.53 |
| Working Capital Days | 919.26 | 1,227.73 | 39.92 | 62.48 | 134.29 | 825.40 | 532.03 | 158.95 | 53.27 | 295.19 | 177.96 | 875.92 |
| ROCE % | -0.26% | 1.89% | -4.32% | 19.61% | 10.17% | -14.61% | -15.03% | 22.59% | 60.95% | -40.88% | 34.88% | 12.08% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.01 | 5.71 | -4.98 | 8.01 | 1.36 |
| Diluted EPS (Rs.) | 3.01 | 5.71 | -4.98 | 8.01 | 1.36 |
| Cash EPS (Rs.) | 1.55 | 5.91 | -4.71 | 8.23 | 1.43 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 24.94 | 20.97 | 15.26 | 20.23 | 12.23 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 24.94 | 20.97 | 15.26 | 20.23 | 12.23 |
| Revenue From Operations / Share (Rs.) | 9.56 | 30.28 | 5.98 | 10.45 | 3.22 |
| PBDIT / Share (Rs.) | 2.44 | 6.59 | -7.09 | 10.11 | 2.78 |
| PBIT / Share (Rs.) | 2.39 | 6.38 | -7.36 | 9.89 | 2.71 |
| PBT / Share (Rs.) | 2.30 | 6.38 | -7.39 | 9.88 | 2.68 |
| Net Profit / Share (Rs.) | 1.50 | 5.71 | -4.98 | 8.01 | 1.36 |
| PBDIT Margin (%) | 25.52 | 21.75 | -118.56 | 96.75 | 86.25 |
| PBIT Margin (%) | 24.96 | 21.08 | -123.04 | 94.61 | 84.15 |
| PBT Margin (%) | 24.10 | 21.07 | -123.44 | 94.55 | 83.13 |
| Net Profit Margin (%) | 15.71 | 18.86 | -83.15 | 76.61 | 42.29 |
| Return on Networth / Equity (%) | 6.02 | 27.23 | -32.61 | 39.56 | 11.14 |
| Return on Capital Employeed (%) | 9.32 | 29.77 | -48.15 | 43.60 | 21.19 |
| Return On Assets (%) | 4.50 | 26.44 | -31.41 | 35.12 | 10.56 |
| Total Debt / Equity (X) | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.47 | 1.62 | 0.30 | 0.58 | 0.25 |
| Current Ratio (X) | 4.29 | 137.98 | 27.37 | 189.17 | 118.77 |
| Quick Ratio (X) | 3.29 | 59.81 | 22.32 | 189.17 | 118.77 |
| Inventory Turnover Ratio (X) | 1.64 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 29.55 | 1770.36 | -298.50 | 1674.16 | 83.93 |
| Interest Coverage Ratio (Post Tax) (X) | 19.19 | 1536.47 | -208.36 | 1326.56 | 42.16 |
| Enterprise Value (Cr.) | 24.69 | 8.89 | 5.21 | 6.73 | 0.91 |
| EV / Net Operating Revenue (X) | 2.82 | 0.96 | 2.85 | 2.11 | 0.92 |
| EV / EBITDA (X) | 11.04 | 4.42 | -2.40 | 2.18 | 1.08 |
| MarketCap / Net Operating Revenue (X) | 2.02 | 0.96 | 2.86 | 2.14 | 1.07 |
| Price / BV (X) | 0.77 | 1.40 | 1.12 | 1.11 | 0.28 |
| Price / Net Operating Revenue (X) | 2.02 | 0.96 | 2.86 | 2.14 | 1.07 |
| EarningsYield | 0.07 | 0.19 | -0.29 | 0.35 | 0.39 |
After reviewing the key financial ratios for Moongipa Capital Finance Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.01. This value is below the healthy minimum of 5. It has decreased from 5.71 (Mar 24) to 3.01, marking a decrease of 2.70.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.01. This value is below the healthy minimum of 5. It has decreased from 5.71 (Mar 24) to 3.01, marking a decrease of 2.70.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.55. This value is below the healthy minimum of 3. It has decreased from 5.91 (Mar 24) to 1.55, marking a decrease of 4.36.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.94. It has increased from 20.97 (Mar 24) to 24.94, marking an increase of 3.97.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.94. It has increased from 20.97 (Mar 24) to 24.94, marking an increase of 3.97.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 9.56. It has decreased from 30.28 (Mar 24) to 9.56, marking a decrease of 20.72.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.44. This value is within the healthy range. It has decreased from 6.59 (Mar 24) to 2.44, marking a decrease of 4.15.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 6.38 (Mar 24) to 2.39, marking a decrease of 3.99.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.30. This value is within the healthy range. It has decreased from 6.38 (Mar 24) to 2.30, marking a decrease of 4.08.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.50. This value is below the healthy minimum of 2. It has decreased from 5.71 (Mar 24) to 1.50, marking a decrease of 4.21.
- For PBDIT Margin (%), as of Mar 25, the value is 25.52. This value is within the healthy range. It has increased from 21.75 (Mar 24) to 25.52, marking an increase of 3.77.
- For PBIT Margin (%), as of Mar 25, the value is 24.96. This value exceeds the healthy maximum of 20. It has increased from 21.08 (Mar 24) to 24.96, marking an increase of 3.88.
- For PBT Margin (%), as of Mar 25, the value is 24.10. This value is within the healthy range. It has increased from 21.07 (Mar 24) to 24.10, marking an increase of 3.03.
- For Net Profit Margin (%), as of Mar 25, the value is 15.71. This value exceeds the healthy maximum of 10. It has decreased from 18.86 (Mar 24) to 15.71, marking a decrease of 3.15.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.02. This value is below the healthy minimum of 15. It has decreased from 27.23 (Mar 24) to 6.02, marking a decrease of 21.21.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.32. This value is below the healthy minimum of 10. It has decreased from 29.77 (Mar 24) to 9.32, marking a decrease of 20.45.
- For Return On Assets (%), as of Mar 25, the value is 4.50. This value is below the healthy minimum of 5. It has decreased from 26.44 (Mar 24) to 4.50, marking a decrease of 21.94.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.30. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.30, marking an increase of 0.30.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has decreased from 1.62 (Mar 24) to 0.47, marking a decrease of 1.15.
- For Current Ratio (X), as of Mar 25, the value is 4.29. This value exceeds the healthy maximum of 3. It has decreased from 137.98 (Mar 24) to 4.29, marking a decrease of 133.69.
- For Quick Ratio (X), as of Mar 25, the value is 3.29. This value exceeds the healthy maximum of 2. It has decreased from 59.81 (Mar 24) to 3.29, marking a decrease of 56.52.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.64. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 1.64, marking an increase of 1.64.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 29.55. This value is within the healthy range. It has decreased from 1,770.36 (Mar 24) to 29.55, marking a decrease of 1,740.81.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 19.19. This value is within the healthy range. It has decreased from 1,536.47 (Mar 24) to 19.19, marking a decrease of 1,517.28.
- For Enterprise Value (Cr.), as of Mar 25, the value is 24.69. It has increased from 8.89 (Mar 24) to 24.69, marking an increase of 15.80.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.82. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 2.82, marking an increase of 1.86.
- For EV / EBITDA (X), as of Mar 25, the value is 11.04. This value is within the healthy range. It has increased from 4.42 (Mar 24) to 11.04, marking an increase of 6.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 2.02, marking an increase of 1.06.
- For Price / BV (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 1.40 (Mar 24) to 0.77, marking a decrease of 0.63.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 2.02, marking an increase of 1.06.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.19 (Mar 24) to 0.07, marking a decrease of 0.12.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Moongipa Capital Finance Ltd:
- Net Profit Margin: 15.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.32% (Industry Average ROCE: 15.81%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.02% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 19.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.29
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 12.5 (Industry average Stock P/E: 52.39)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.3
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 15.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 18/14, W.E.A. Pusa Lane, Karol Bagh, New Delhi Delhi 110005 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr.(Ms.) Pooja Jain | Whole Time Director |
| Mr. Sanjay Jain | Non Executive Director |
| Mr. Ajay Prakash Narain | Independent Director |
| Mr. Rajesh Kumar | Independent Director |
FAQ
What is the intrinsic value of Moongipa Capital Finance Ltd?
Moongipa Capital Finance Ltd's intrinsic value (as of 18 January 2026) is ₹22.70 which is 37.58% higher the current market price of ₹16.50, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹15.2 Cr. market cap, FY2025-2026 high/low of ₹26.2/15.0, reserves of ₹15.21 Cr, and liabilities of ₹32.64 Cr.
What is the Market Cap of Moongipa Capital Finance Ltd?
The Market Cap of Moongipa Capital Finance Ltd is 15.2 Cr..
What is the current Stock Price of Moongipa Capital Finance Ltd as on 18 January 2026?
The current stock price of Moongipa Capital Finance Ltd as on 18 January 2026 is ₹16.5.
What is the High / Low of Moongipa Capital Finance Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Moongipa Capital Finance Ltd stocks is ₹26.2/15.0.
What is the Stock P/E of Moongipa Capital Finance Ltd?
The Stock P/E of Moongipa Capital Finance Ltd is 12.5.
What is the Book Value of Moongipa Capital Finance Ltd?
The Book Value of Moongipa Capital Finance Ltd is 26.6.
What is the Dividend Yield of Moongipa Capital Finance Ltd?
The Dividend Yield of Moongipa Capital Finance Ltd is 0.00 %.
What is the ROCE of Moongipa Capital Finance Ltd?
The ROCE of Moongipa Capital Finance Ltd is 12.1 %.
What is the ROE of Moongipa Capital Finance Ltd?
The ROE of Moongipa Capital Finance Ltd is 9.43 %.
What is the Face Value of Moongipa Capital Finance Ltd?
The Face Value of Moongipa Capital Finance Ltd is 10.0.